Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2022-01-26
2022-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cranberry Juice for Treatment of Urinary Tract Infections
NCT00093054
Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
NCT00305071
Cranberry for the Prevention of Urinary Tract Infections
NCT05730998
Cranberry for the Prevention of Urinary Tract Infections
NCT02454309
Cranberry on Urinary Tract Infections
NCT01881165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
using fosfomycin
The patients in this group; have been prescribed fosfomycin for 7 days (3 doses, two days apart).
Fosfomycin
In this group with urinary tract inflammation; Fosfomycin was prescribed for 7 days (3 doses, 2 days apart). There are 80 patients in total.
using cranberry extract
The patients in this group; took 7 days (1 tablet each day) of cranberry tablets.
Cranberry
In this group with urinary tract inflammation; 7 days (used every day) cranberry tablet was given. There are 80 patients in total.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fosfomycin
In this group with urinary tract inflammation; Fosfomycin was prescribed for 7 days (3 doses, 2 days apart). There are 80 patients in total.
Cranberry
In this group with urinary tract inflammation; 7 days (used every day) cranberry tablet was given. There are 80 patients in total.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who have urinary tract inflammation
* who haven't kidney dissease previous
Exclusion Criteria
* Who have kidney inflammation
* Pregnant patients
* Who have blood test abnormal (WBC, Ure, Creatin, CRP high level)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kırklareli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oya Guven, MD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oya Guven
Role: STUDY_DIRECTOR
Kırklareli University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oya Guven, MD
Kırklareli, Center, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gray M. Are cranberry juice or cranberry products effective in the prevention or management of urinary tract infection? J Wound Ostomy Continence Nurs. 2002 May;29(3):122-6. doi: 10.1067/mjw.2002.124016. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kırklareli University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.